Vestibular Infant Screening - Rehabilitation
Launched by UNIVERSITY HOSPITAL, GHENT · Dec 11, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Vestibular Infant Screening - Rehabilitation, aims to explore how a specific rehabilitation program can help children aged 3 to 17 who have vestibular disorders, which can affect balance and coordination. The program, known as the VIS-REHAB protocol, includes exercises to improve stability and gaze control. Researchers want to see how effective this program is compared to a period when the children do not receive any therapy. They will look at improvements in balance, eye movements, motor skills, and overall quality of life.
To participate, children must have a diagnosed vestibular dysfunction, which means they have issues with their balance system, and they can have hearing loss or use cochlear implants. However, children with severe cognitive or physical disabilities that prevent them from following instructions or standing and walking independently will not be eligible. Families can expect that the trial will involve both active rehabilitation and a time with no therapy, allowing researchers to gather important information about the benefits of the VIS-REHAB program. This study is not yet recruiting participants, so interested families will need to wait for further announcements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with identified vestibular dysfunction
- • With or without concomitant hearing loss and/or cochlear implant (CI)
- Exclusion Criteria:
- • Children incapable to understand simple instructions (due to severe cognitive disorders, impaired language comprehension, etc.)
- • Severe disorders of other primary sensory input systems for balance function
- • Severe neuromotor disorders (incapable of independent standing and walking)
- • Severe muscle tone disorders (e.g. cerebral palsy)
- • Severe orthopaedic dysfunctions
- • Patients with vision problems that cannot be corrected for
- • Children with planned CI-surgery within 5 months before or during the study period
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, East Flanders, Belgium
Patients applied
Trial Officials
Leen Maes, PhD
Principal Investigator
University Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported